Siglec15 is broadly expression on human cancer cells and tumor infiltrating myeloid cells, and it has been reported that SIGLEC15+ tumor-associated macrophage, rather than SIGLEC15+ PDAC cells, correlated with poor prognosis in PDAC31. Here, SIGLEC15 is linked to cancer.